Freeze-dried matrices for ocular administration of bevacizumab: a comparison between subconjunctival and intravitreal administration in rabbits

A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles

(2017) Flávia Sousa et al.   Scientific Reports

Recent perspectives on the delivery of biologics to back of the eye

(2016) Mary Joseph et al.   Expert Opinion on Drug Delivery

Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation

(2016) Jayamanti Pandit et al.   Artificial Cells Nanomedicine and Biotechnology

Recent Progress in Using Biomaterials as Vitreous Substitutes

(2015) Xinyi Su et al.   BIOMACROMOLECULES

Silk hydrogels for sustained ocular delivery of anti-vascular endothelial growth factor (anti-VEGF) therapeutics

(2015) Michael L. Lovett et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Rabbit as an animal model for intravitreal pharmacokinetics: Clinical predictability and quality of the published data

(2015) Eva M. del Amo et al.   EXPERIMENTAL EYE RESEARCH

An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease

(2015) Binbin Xie et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Bevacizumab loaded solid lipid nanoparticles prepared by the coacervation technique: preliminary in vitro studies

(2015) Luigi Battaglia et al.   NANOTECHNOLOGY

In vitroevaluation of some parameters involved in mucoadhesion of aqueous polymeric dispersions

(2014) Susi Burgalassi et al.   PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY

Topical Delivery of Avastin to the Posterior Segment of the Eye In Vivo Using Annexin A5-associated Liposomes

(2014) Benjamin M. Davis et al.   Small

Pharmacokinetics of Intravitreally Injected Bevacizumab in Vitrectomized Eyes

(2013) Jeeyun Ahn et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Nanoparticles in Porous Microparticles Prepared by Supercritical Infusion and Pressure Quench Technology for Sustained Delivery of Bevacizumab

(2013) Sarath K. Yandrapu et al.   MOLECULAR PHARMACEUTICS

Reentanglement Kinetics of Freeze-Dried Polymers above the Glass Transition Temperature

(2012) Chao Teng et al.   MACROMOLECULES

Sustained Release of a Monoclonal Antibody from Electrochemically Prepared Mesoporous Silicon Oxide

(2010) Jennifer S. Andrew et al.   ADVANCED FUNCTIONAL MATERIALS

Drug delivery to the posterior segment of the eye

(2010) Thilini Rasika Thrimawithana et al.   DRUG DISCOVERY TODAY

Effect of lyophilization on the in vitro biological activity of bevacizumab

(2010) L Taniwaki et al.   EYE

Aqueous Humor Concentration of Bevacizumab After Subconjunctival Injection in Rabbit

(2010) Moon Jung Kim et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

PREPARATION, CHARACTERIZATION, AND IN VIVO EVALUATION OF NANOLIPOSOMES-ENCAPSULATED BEVACIZUMAB (AVASTIN) FOR INTRAVITREAL ADMINISTRATION

(2009) MAJID ABRISHAMI et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES